US Stock MarketDetailed Quotes

Alto Neuroscience (ANRO)

Watchlist
  • 24.520
  • -1.190-4.63%
Close Apr 24 16:00 ET
  • 24.520
  • 0.0000.00%
Post 20:01 ET
783.30MMarket Cap-11.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Alto Neuroscience (ANRO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-9.16%-51.77M
11.56%-11.52M
15.42%-9.92M
-17.83%-13.78M
-50.74%-16.56M
-41.78%-47.42M
-12.99%-13.02M
-51.01%-11.73M
-76.25%-11.69M
-45.97%-10.98M
Net income from continuing operations
-2.94%-63.24M
-6.45%-16.18M
15.50%-14.18M
-10.46%-17.71M
-13.06%-15.17M
-69.21%-61.43M
-35.52%-15.2M
-83.60%-16.78M
-85.04%-16.03M
-84.20%-13.42M
Operating gains losses
1,509.62%837K
--0
2,750.00%114K
-94.44%1K
197.12%722K
-62.86%52K
-93.74%30K
101.77%4K
117.65%18K
2,309.09%243K
Depreciation and amortization
31.67%661K
-7.65%157K
34.43%164K
49.56%169K
76.29%171K
34.58%502K
51.79%170K
93.65%122K
0.89%113K
12.79%97K
Other non cash items
3.86%1.83M
46.98%463K
239.46%499K
-48.48%457K
-0.48%411K
1,066.89%1.76M
190.52%315K
-10.37%147K
461.39%887K
133.33%413K
Change In working capital
-99.19%33K
2,021.21%2.1M
-53.45%1.3M
-9.44%1.3M
-1,727.06%-4.66M
681.66%4.06M
108.56%99K
234.05%2.79M
138.33%1.43M
73.87%-255K
-Change in receivables
----
----
----
----
----
----
----
--0
--0
121.62%8K
-Change in prepaid assets
121.81%101K
45.78%656K
-15.59%628K
310.48%509K
5.00%-1.69M
-259.11%-463K
0.00%450K
1,007.32%744K
-67.96%124K
-283.84%-1.78M
-Change in payables and accrued expense
-101.50%-68K
511.40%1.44M
-67.24%669K
-39.82%786K
-294.43%-2.97M
557.33%4.52M
72.60%-351K
228.82%2.04M
794.52%1.31M
421.26%1.53M
Cash from discontinued investing activities
Operating cash flow
-9.16%-51.77M
11.56%-11.52M
15.42%-9.92M
-17.83%-13.78M
-50.74%-16.56M
-41.78%-47.42M
-12.99%-13.02M
-51.01%-11.73M
-76.25%-11.69M
-45.97%-10.98M
Investing cash flow
Cash flow from continuing investing activities
98.84%-24K
0
0
0
89.29%-24K
-341.49%-2.08M
-43.75%-506K
-2,237.21%-1.01M
-529.63%-340K
-966.67%-224K
Capital expenditure reported
98.84%-24K
--0
--0
--0
89.29%-24K
-341.49%-2.08M
-43.75%-506K
-2,237.21%-1.01M
-529.63%-340K
-966.67%-224K
Cash from discontinued investing activities
Investing cash flow
98.84%-24K
--0
--0
--0
89.29%-24K
-341.49%-2.08M
-43.75%-506K
-2,237.21%-1.01M
-529.63%-340K
-966.67%-224K
Financing cash flow
Cash flow from continuing financing activities
-55.72%60.08M
102,318.37%50.19M
-88.38%153K
361.97%613K
-93.22%9.13M
99.16%135.69M
-99.89%49K
2,587.76%1.32M
-358.82%-234K
438.24%134.56M
Net issuance payments of debt
--9.48M
--0
--0
--0
--9.48M
--0
--0
--0
--0
--0
Net common stock issuance
-63.78%49.83M
--49.83M
--0
--0
--0
--137.58M
--0
--0
--0
--137.58M
Net preferred stock issuance
----
----
----
----
----
--0
--0
266.67%100K
--0
--0
Proceeds from stock option exercised by employees
275.94%703K
618.37%352K
128.36%153K
--0
1,880.00%198K
3.31%187K
68.97%49K
-38.53%67K
41.86%61K
--10K
Net other financing activities
103.23%67K
--0
--0
414.36%613K
81.98%-546K
-1.17%-2.08M
--0
--1.15M
---195K
---3.03M
Cash from discontinued financing activities
Financing cash flow
-55.72%60.08M
102,318.37%50.19M
-88.38%153K
361.97%613K
-93.22%9.13M
99.16%135.69M
-99.89%49K
2,587.76%1.32M
-358.82%-234K
438.24%134.56M
Net cash flow
Beginning cash position
104.40%168.73M
-24.09%138.32M
-23.52%148.09M
-21.68%161.25M
104.40%168.73M
70.75%82.55M
255.25%182.2M
228.01%193.62M
213.01%205.9M
70.75%82.55M
Current changes in cash
-90.39%8.29M
386.90%38.67M
14.45%-9.77M
-7.32%-13.17M
-106.04%-7.45M
151.93%86.19M
-143.12%-13.48M
-47.11%-11.41M
-82.02%-12.27M
606.69%123.35M
Effect of exchange rate changes
-172.73%-30K
-116.67%-1K
42.86%-4K
40.00%-3K
-340.00%-22K
-37.50%-11K
50.00%6K
-138.89%-7K
54.55%-5K
73.68%-5K
End cash Position
4.89%176.98M
4.89%176.98M
-24.09%138.32M
-23.52%148.09M
-21.68%161.25M
104.40%168.73M
104.40%168.73M
255.25%182.2M
228.01%193.62M
213.01%205.9M
Free cash flow
-4.63%-51.79M
14.87%-11.52M
22.10%-9.92M
-14.50%-13.78M
-47.94%-16.58M
-45.94%-49.5M
-13.90%-13.53M
-63.05%-12.73M
-79.91%-12.03M
-48.54%-11.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -9.16%-51.77M11.56%-11.52M15.42%-9.92M-17.83%-13.78M-50.74%-16.56M-41.78%-47.42M-12.99%-13.02M-51.01%-11.73M-76.25%-11.69M-45.97%-10.98M
Net income from continuing operations -2.94%-63.24M-6.45%-16.18M15.50%-14.18M-10.46%-17.71M-13.06%-15.17M-69.21%-61.43M-35.52%-15.2M-83.60%-16.78M-85.04%-16.03M-84.20%-13.42M
Operating gains losses 1,509.62%837K--02,750.00%114K-94.44%1K197.12%722K-62.86%52K-93.74%30K101.77%4K117.65%18K2,309.09%243K
Depreciation and amortization 31.67%661K-7.65%157K34.43%164K49.56%169K76.29%171K34.58%502K51.79%170K93.65%122K0.89%113K12.79%97K
Other non cash items 3.86%1.83M46.98%463K239.46%499K-48.48%457K-0.48%411K1,066.89%1.76M190.52%315K-10.37%147K461.39%887K133.33%413K
Change In working capital -99.19%33K2,021.21%2.1M-53.45%1.3M-9.44%1.3M-1,727.06%-4.66M681.66%4.06M108.56%99K234.05%2.79M138.33%1.43M73.87%-255K
-Change in receivables ------------------------------0--0121.62%8K
-Change in prepaid assets 121.81%101K45.78%656K-15.59%628K310.48%509K5.00%-1.69M-259.11%-463K0.00%450K1,007.32%744K-67.96%124K-283.84%-1.78M
-Change in payables and accrued expense -101.50%-68K511.40%1.44M-67.24%669K-39.82%786K-294.43%-2.97M557.33%4.52M72.60%-351K228.82%2.04M794.52%1.31M421.26%1.53M
Cash from discontinued investing activities
Operating cash flow -9.16%-51.77M11.56%-11.52M15.42%-9.92M-17.83%-13.78M-50.74%-16.56M-41.78%-47.42M-12.99%-13.02M-51.01%-11.73M-76.25%-11.69M-45.97%-10.98M
Investing cash flow
Cash flow from continuing investing activities 98.84%-24K00089.29%-24K-341.49%-2.08M-43.75%-506K-2,237.21%-1.01M-529.63%-340K-966.67%-224K
Capital expenditure reported 98.84%-24K--0--0--089.29%-24K-341.49%-2.08M-43.75%-506K-2,237.21%-1.01M-529.63%-340K-966.67%-224K
Cash from discontinued investing activities
Investing cash flow 98.84%-24K--0--0--089.29%-24K-341.49%-2.08M-43.75%-506K-2,237.21%-1.01M-529.63%-340K-966.67%-224K
Financing cash flow
Cash flow from continuing financing activities -55.72%60.08M102,318.37%50.19M-88.38%153K361.97%613K-93.22%9.13M99.16%135.69M-99.89%49K2,587.76%1.32M-358.82%-234K438.24%134.56M
Net issuance payments of debt --9.48M--0--0--0--9.48M--0--0--0--0--0
Net common stock issuance -63.78%49.83M--49.83M--0--0--0--137.58M--0--0--0--137.58M
Net preferred stock issuance ----------------------0--0266.67%100K--0--0
Proceeds from stock option exercised by employees 275.94%703K618.37%352K128.36%153K--01,880.00%198K3.31%187K68.97%49K-38.53%67K41.86%61K--10K
Net other financing activities 103.23%67K--0--0414.36%613K81.98%-546K-1.17%-2.08M--0--1.15M---195K---3.03M
Cash from discontinued financing activities
Financing cash flow -55.72%60.08M102,318.37%50.19M-88.38%153K361.97%613K-93.22%9.13M99.16%135.69M-99.89%49K2,587.76%1.32M-358.82%-234K438.24%134.56M
Net cash flow
Beginning cash position 104.40%168.73M-24.09%138.32M-23.52%148.09M-21.68%161.25M104.40%168.73M70.75%82.55M255.25%182.2M228.01%193.62M213.01%205.9M70.75%82.55M
Current changes in cash -90.39%8.29M386.90%38.67M14.45%-9.77M-7.32%-13.17M-106.04%-7.45M151.93%86.19M-143.12%-13.48M-47.11%-11.41M-82.02%-12.27M606.69%123.35M
Effect of exchange rate changes -172.73%-30K-116.67%-1K42.86%-4K40.00%-3K-340.00%-22K-37.50%-11K50.00%6K-138.89%-7K54.55%-5K73.68%-5K
End cash Position 4.89%176.98M4.89%176.98M-24.09%138.32M-23.52%148.09M-21.68%161.25M104.40%168.73M104.40%168.73M255.25%182.2M228.01%193.62M213.01%205.9M
Free cash flow -4.63%-51.79M14.87%-11.52M22.10%-9.92M-14.50%-13.78M-47.94%-16.58M-45.94%-49.5M-13.90%-13.53M-63.05%-12.73M-79.91%-12.03M-48.54%-11.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -